Structure–activity relationship study of a series of novel oxazolidinone derivatives as IL-6 signaling blockers

Bioorganic & Medicinal Chemistry Letters
2016.0

Abstract

A series of oxazolidinone and indole derivatives were synthesized and evaluated as IL-6 signaling blockers by measuring the effects of these compounds on IL-6-induced luciferase expression in human hepatocarcinoma HepG2 cells transfected with p-STAT3-Luc. Among different compounds screened, compound 4d was emerged as the most potent IL-6 signaling blockers with IC50 value of 5.9 μM which was much better than (+)-Madindoline A (IC50=21 μM), a known inhibitor of IL-6.

Knowledge Graph

Similar Paper

Structure–activity relationship study of a series of novel oxazolidinone derivatives as IL-6 signaling blockers
Bioorganic & Medicinal Chemistry Letters 2016.0
Madindoline, a Novel Inhibitor of IL-6 Activity from Streptomyces sp. K93-0711. I. Taxonomy, Fermentation, Isolation and Biological Activities.
The Journal of Antibiotics 1996.0
Design, synthesis, and biological activities of madindoline analogues
Bioorganic & Medicinal Chemistry Letters 2006.0
Benzobis(imidazole) derivatives as STAT3 signal inhibitors with antitumor activity
Bioorganic & Medicinal Chemistry 2022.0
Indole derivatives as potent inhibitors of 5-lipoxygenase: Design, synthesis, biological evaluation, and molecular modeling
Bioorganic & Medicinal Chemistry Letters 2007.0
Novel indolizine compounds as potent inhibitors of phosphodiesterase IV (PDE4): structure–activity relationship
Med. Chem. Commun. 2010.0
Madindolines, Novel Inhibitors of IL-6 Activity from Streptomyces sp. K93-0711. II. Physico-chemical Properties and Structural Elucidation.
The Journal of Antibiotics 1997.0
Synthesis and anti-tumor activity of glycosyl oxadiazoles derivatives
Bioorganic & Medicinal Chemistry Letters 2014.0
Structure–activity relationships of 6-(aminomethylphenoxy)-benzoxaborole derivatives as anti-inflammatory agent
Bioorganic & Medicinal Chemistry Letters 2013.0
Synthesis and biological evaluation of 4,5-diphenyloxazolone derivatives on route towards selective COX-2 inhibitors
European Journal of Medicinal Chemistry 2009.0